‹ณˆ๕๎•๑
Ž–ผ ฌ—ั@ƒJƒIƒ‹
ƒtƒŠƒKƒi ƒRƒoƒ„ƒV@ƒJƒIƒ‹
E–ผ y‹ณŽ๖
Šwˆส ”ŽŽmi–๒Šwj
Œค‹†Žบ –๒•จŠwiˆๅ•@@ˆใ–๒Œn‘‡Œค‹†“I@4ŠKj
“d˜b”ิ† 043-226-2895
ƒ[ƒ‹ƒAƒhƒŒƒX kaoruk—faculty.chiba-u.jp@i—‚อ‘SŠp•\‹Lj
’S“–u‹` “ลซŠw
—ีฐ–๒—Šw
–๒•จŽก—รŠw
•a‘ิถ‰ปŠw
–๒—ŠwŽภK
Ž–‘OŽภ–ฑŽภK
๊–ๅ•ช–์ –๒•จ‘ใŽำŠw
Œค‹†ƒe[ƒ} –๒•จ“ฎ‘ิE–๒Œ๘“ลซ”ญŒป‚ฬƒƒJƒjƒYƒ€‚ฦ‚ป‚ฬ—\‘ช–@‚ฬŠm—ง
Žๅ‚ศŒค‹†‹ฦั Kazuki Y, Kobayashi K, Aueviriyavit S, Oshima T, Kuroiwa Y, Tsukazaki Y, Senda N, Kawakami H, Ohtsuki S, Abe S, Takiguchi M, Hoshiya H, Kajitani N, Takehara S, Kubo K, Terasaki T, Chiba K, Tomizuka K, Oshimura M.Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. Hum Mol Genet. 22, 578-592 (2013).

Kobayashi K, Yoshida A, Ejiri Y, Takagi S, Mimura H, Hosoda M, Matsuura T, Chiba K. Increased expression of drug-metabolizing enzymes in human hepatocarcinoma FLC-4 cells cultured on micro-space cell culture plates. Drug Metab Pharmacokinet. 27, 478-485 (2012).

Saito K, Kobayashi K, Mizuno Y, Furihata T, Chiba K. Constitutive androstane/active receptor is a target of retinoic acid receptor in humans .Biochem Pharmacol.;80, 129-135 (2010).

Kobayashi K, Morita J, Chiba K, Wanibuchi A, Kimura M, Irie S, Urae A, Ishizaki T. Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans. Pharmacogenetics.14, 549-556 (2004).

Kobayashi K, Sueyoshi T, Inoue K, Moore R, Negishi M. Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol. 64, 1069-1075 (2003).
Š‘ฎŠw‰๏ “๚–{–๒•จ“ฎ‘ิ‰๏
“๚–{—ีฐ–๒—Šw‰๏
“๚–{–๒Šw‰๏
International Society for the Study of Xenobiotics (ISSX)
American Society for Pharmacology and Experimental Therapeutics (ASPET)
ŠwŠO‚ล‚ฬ‹ณˆ็EŒค‹†Šˆ“ฎ “๚–{–๒•จ“ฎ‘ิŠw‰๏•]‹cˆ๕
Editorial Advisory Board of Journal of Biochemical and Molecular Toxicology
Editorial Advisory Board of the Drug Metabolism and Pharmacokinetics
“เŠt•{H•iˆภ‘Sˆฯˆ๕‰๏iŠํ‹๏E—eŠํ•๏‘•๊–ๅ’ฒธ‰๏j๊–ๅˆฯˆ๕